Protecting single-kidney allografts from long-term functional deterioration.
Remuzzi
G
G
Department of Transplant Immunology and Innovative Antirejection Therapies, Ospedali Riuniti Bergamo-Mario Negri Institute for Pharmacological Research, Italy.
Perico
N
N
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000517:prevention & control; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D011379:Prognosis; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents